Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
GSDME-mediated target cell pyroptosis by CAR T cells activates macrophages to release proinflammatory cytokines for CRS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment for CRS and associated neurotoxicity primarily targets IL-6, likely arising from monocytes or activated endothelium [1, 6, 11–17].”
From Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm (2021) · cites this paper as [14]
In the citing paper
“Tumor lysis most likely also contributes to the cytokine storm through the induction of pyroptosis in target cells.55”
From Cytokine storm (2020) · cites this paper as [55]
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Self-citationChimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199
U.S. Department of Health and Human Services
(2006) · Encyclopedia of Sexual Behavior and the Law · doi:10.4135/9781452240107.n226 · Cited by 3,170
Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death
Shi, J., Gao, W., & Shao, F. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.10.004 · Cited by 3,088
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Pore-forming activity and structural autoinhibition of the gasdermin family
Ding, J., Wang, K., Liu, W., She, Y., Sun, Q., Shi, J., Sun, H., Wang, D.-C., & Shao, F. (2016) · Nature · doi:10.1038/nature18590 · Cited by 2,771
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Park, J. H., Rivière, I., Gonen, M., Wang, X., Sénéchal, B., Curran, K. J., Sauter, C., Wang, Y., Santomasso, B., Mead, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709919 · Cited by 2,688
Cited by
Items 301–400 of 567
Zeng, Y., Cai, Y., Chai, P., Mao, Y., Chen, Y., Wang, L., Zeng, K., Zhan, Z., Xie, Y., Li, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.961933 · Cited by 20
Self-citationHe, J., Zheng, P., Chen, Y., Qi, J., Ye, C., Li, D., Yang, Y., Yang, Y., Liu, Q., Hu, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.991857 · Cited by 19
Self-citationPrognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
Peng, L., Duan, S., Li, R.-Q., Wang, D., Han, Y., Huang, T., Yu, Y.-P., Ou, C., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1043862 · Cited by 15
Pyroptosis, Metabolism, and Oxidation in Tumorigenesis: Mechanisms and Therapeutic Implications
Cao, Q., Zhang, J., Sun, D.-Y., Fu, J., Wu, W., Chen, X., Li, D., & Wang, P. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0257 · Cited by 17
“…GSDMD protein are observed in tumor-infiltrating lymphocytes in LUAD and LUSC tissue samples (Xi et al., 2019) Subsequently, other studies have clarified the mechanism of NK-and CTL-induced tumor cell pyroptosis via the release of granzyme (Liu et al., 2020; Zhang et al., 2020c; Zhou et al., 2020).”
InfluentialSelf-citationZhou, L., Fu, W., Wu, S., Xu, K., Qiu, L., Xu, Y., Yan, X., Zhang, Q., Zhang, M., Wang, L., et al. (2023) · British Journal of Haematology · doi:10.1111/bjh.18873 · Cited by 16
Self-citationHao, Y., Xie, C., Zuo, Z., Xie, D., & Wang, Q. (2023) · Advanced Materials · doi:10.1002/adma.202309839 · Cited by 17
Role of tumor cell pyroptosis in anti-tumor immunotherapy
Zhang, L., Bai, H., Zhou, J., Ye, L., & Gao, L. (2024) · Cell Insight · doi:10.1016/j.cellin.2024.100153 · Cited by 16
“T cells induced GSDME-dependent tumor cell pyroptosis via the activation of pro-caspase-3 (Liu et al., 2020).”
BackgroundResultInfluentialAn explanation of the role of pyroptosis playing in epilepsy
Zhang, X., Zhao, T., Su, S., Li, L., Zhang, Y., Yan, J., Cui, X., Sun, Y., Zhao, J., Han, X., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112386 · Cited by 16
Self-citationActivation of GSDME compensates for GSDMD deficiency in a mouse model of NLRP3 inflammasomopathyPreprint
Wang, C., Yang, T., Xiao, J., Xu, C., Alippe, Y., Sun, K., Kanneganti, T., Monahan, J. B., Abu‐Amer, Y., Lieberman, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.06.425634 · Cited by 15
Pyroptosis in Spinal Cord Injury: Implications for Pathogenesis and Therapeutic Approaches
Gu, G., Yu, H., Zou, H., Kou, W., Zhang, P., Gu, G., Lu, J., Shi, W., Chu, P., Zhang, Y., et al. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2906210 · Cited by 14
Self-citationGasdermins, Executors of Pyroptosis: A Decade in Perspective
Zhou, B., & Abbott, D. W. (2025) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042624-121548 · Cited by 15
Single-cell sequencing reveals VEGFR as a potential target for CAR-T cell therapy in chordoma
Wu, H., Li, X., Zhang, B., Liu, P., Qi, M., Du, Y., Zhang, C., Duan, W., & Chen, Z. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02635-5 · Cited by 15
New insights into constitutive neutrophil death
Chen, T., Ren, Q., & Ma, F. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02287-1 · Cited by 15
Ubiquitination is a major modulator for the activation of inflammasomes and pyroptosis
Jiang, Q., Zhu, Z., & Mao, X. (2023) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2023.194955 · Cited by 14
Role of PANoptosis in cancer: Molecular mechanisms and therapeutic opportunities
Wang, W., Zhou, Z. Q., Ge, F., Tayir, M., Hao, M.-Y., & Wu, D. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02173-2 · Cited by 17
“Gasdermin D (GSDMD), a pore-forming protein and the executor of pyroptosis, is one of the key components of the inflammasome [ 20].”
Zhang, Z., Yang, Z., Wang, S., Wang, X., & Mao, J. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102932 · Cited by 18
Self-citationThe role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapy
Gabriel, K., Heinzerling, L., von Baumgarten, L., Subklewe, M. S., & Kobold, S. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120115 · Cited by 19
Liao, K., Chen, S., Yang, G., Huang, X., Wang, T., Long, S., Wang, J., Yin, L., Zou, Q., Liu, Q., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27234 · Cited by 14
“Additionally, CAR-T cell therapy induces cytokine storms, leading to an irreversible damage to the body [6].”
BackgroundHe, Y., Jiang, S., Cui, Y., Liang, J., Zhong, Y., Sun, Y., Moran, M. F., Huang, Z., He, G., & Mao, X. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216797 · Cited by 15
Cell life-or-death events in osteoporosis: All roads lead to mitochondrial dynamics
Li, Z., Liang, S., Ke, L., Wang, M., Gao, K., Li, D., Xu, Z., Li, N., Zhang, P., & Cheng, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107383 · Cited by 19
Pyroptosis Predicts Immunotherapy Outcomes Across Multiple Cancer Types
Li, S., Chen, P., Cheng, B., Liu, Y., Zhang, X., Xu, Q., Huang, M., Dai, X., Huang, K., Zhang, L., et al. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109163 · Cited by 14
Self-citationWang, K., Wang, X., Zhang, M., Ying, Z., Zhu, Z., Tam, K. Y., Li, C., Zhou, G., Gao, F., Zeng, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021416 · Cited by 13
“Numerous studies have shown that GrzB can rapidly activate caspase 3-related signaling pathways in target cells [21], which in turn promote cancer cell apoptosis or inflammatory death [22].”
BackgroundYao, M., Miao, L., Wang, X., & Han, Y. (2025) · Gene · doi:10.1016/j.gene.2025.149546 · Cited by 15
Zeng, X., Huang, X., Yin, L., Yu, H., Wang, S., & Li, L. (2023) · Cancer Genetics · doi:10.1016/j.cancergen.2023.07.007 · Cited by 13
Regulated Necrosis in Glaucoma: Focus on Ferroptosis and Pyroptosis
Duan, C., Miao, S., Chen, X., Wang, Z., Lin, P., Zhang, N., & Yang, N. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03732-x · Cited by 15
“Activated caspase-3 induces apoptosis or lyses GSDME, triggering pyroptosis by forming membrane pores [91].”
Self-citationTumor-Intrinsic SIRPA Drives Pyroptosis Evasion in Head and Neck Cancer
Song, A., Yang, Q.-C., Wang, W., Wang, S., Li, H., Wu, L., & Sun, Z. (2025) · Journal of Dental Research · doi:10.1177/00220345241305590 · Cited by 12
“The activation of caspases or granzymes can cleave gasdermin to produce N-terminal proteins, inducing pyroptosis by drilling pores in the cytomembrane (Broz et al. 2020; Liu et al. 2020; Wang et al. 2022).”
Zhang, J., Xin, S., Mao, J., Liu, X., Wang, T., Liu, J., Song, X., & Song, W. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01368-1 · Cited by 15
“Moreover, granule enzymes A/B can cleave GSDMB and GSDME, respectively, stimulating their pore-forming activity and thus promoting pyropto-sis [116, 117] (Fig.”
Zhu, L., Liu, J., Li, J., Wang, N., Yan, Z., & Su, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1514994 · Cited by 15
Lin, Y., Luo, S., Wei, J., Lin, S., Wang, D., Zhao, X., Feng, Z., Shen, Y., & Chen, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199669 · Cited by 13
“In fact, CAR-T-cell-mediated cytotoxicity extends beyond apoptosis induction in tumor cells to pyroptosis, and the mechanism of CAR-T-mediated elimination diverges from that of natural T cells [38].”
CAR-T cell: Toxicities issues: Mechanisms and clinical management
Wallet, F., Sesques, P., Devic, P., Levrard, M., Ader, F., Friggeri, A., & Bachy, E. (2021) · Bulletin du Cancer · doi:10.1016/j.bulcan.2021.05.003 · Cited by 15
Alb, M., Reiche, K., Rade, M., Sewald, K., Loskill, P., Cipriano, M., Maulana, T. I., van der Meer, A. D., Weener, H. J., Clerbaux, L., et al. (2024) · Journal of Immunotoxicology · doi:10.1080/1547691x.2024.2345158 · Cited by 15
“Therefore, tumor cell death, in addition to cytokines produced from CAR T cells, could be a factor triggering CRS (Liu et al. 2020).”
Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
Xu, C., Ju, D., & Zhang, X. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac006 · Cited by 17
“The mechanism of CRS occurrence is associated with CAR T cell-induced gasdermin E-mediated target cell pyroptosis and cytokines produced by recipient macrophages [68, 69].”
BackgroundInfluentialSelf-citationPhase I CAR-T Clinical Trials Review
Bulsara, S., Wu, M.-F., & Wang, T. (2022) · Anticancer Research · doi:10.21873/anticanres.16076 · Cited by 11
A review focusing on the role of pyroptosis in prostate cancer
Liu, Z., Kuang, S., & Chen, Q. (2023) · Medicine · doi:10.1097/md.0000000000036605 · Cited by 11
“[71] Lymphocyte-derived granzyme A is also capable of cleaving GSDMB to produce pore-forming N-GSDMB in GSDMB-expressed cancer cells, so as to induce pyroptosis in cancer cells.”
BackgroundCardiotoxic profiles of CAR-T therapy and bispecific T-cell engagers in hematological cancers
Karthikeyan, B., Sunder, S. S., Puzanov, I. J., Olejniczak, S. H., Pokharel, S., & Sharma, U. C. (2024) · Communications Medicine · doi:10.1038/s43856-024-00540-9 · Cited by 13
“Meanwhile, HMGB1 binds to TLR2 and TLR4 found on surface of macrophages, which leads to adaptor proteins MyD88 and TRIF activating mitogen-activated protein kinases (MAPKs) and I κ B kinase (IKK) that in turn regulate the release of cytokines, including IL-6 42,43,46 .”
Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis
Floch, A.-C. L., Imbert, C., Boucherit, N., Gorvel, L., Fattori, S., Orlanducci, F., Roy, A. L., Archetti, L., Crescence, L., Panicot‐Dubois, L., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0868 · Cited by 11
Pyroptosis induced by natural products and their derivatives for cancer therapy
Wen, Y., Li, Y., Li, B., Liu, P., Qiu, M., Li, Z., Xu, J., Bi, B., Zhang, S., Deng, X., et al. (2024) · Biomaterials Science · doi:10.1039/d4bm01023j · Cited by 11
Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation
Mamun, A. A., Geng, P., Wang, S., & Shao, C. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s486878 · Cited by 13
“109 The activation of caspases-3 and GSDME pathways induces pyroptosis.”
BackgroundLi, Y., Lv, J., Shi, W., Feng, J. C., Liu, M., Gan, S., Wu, H., Fan, W., & Shi, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.710110 · Cited by 15
“The cleavage of GSDMD and GSDME in cancer cells could be induced by various therapeutic strategies, including chemotherapy drugs (56, 71–74, 87), molecular target therapies (62, 88), or immune cell therapy (8, 75).”
BackgroundSelf-citationBurning down the house: Pyroptosis in the tumor microenvironment of hepatocellular carcinoma
Cheng, C., Hsu, S., Chen, Y., Liu, W., Shu, E.-D., Chien, C., Chiu, C., & Chang, W. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122627 · Cited by 10
Magneto‐Endosomalytic Therapy for Cancer
Zhao, P., Han, Y., Nguyen, H. M., Corey, E., & Gao, X. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101010 · Cited by 11
Lai, M., Liu, Q., Chen, W., Qi, X., Yang, J., Li, J., Yuan, M., Liu, Z., He, Q., Cao, J., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8346816 · Cited by 10
“Besides, GSDME-mediated pyroptosis was reportedly essential in triggering cytokine storm during chimeric antigen receptor T cell therapy [61].”
Li, B., Li, Z., Ying, T., Beibei, Y., Ni, W., Yiming, Y., Cui, Q., & Qingjun, Z. (2023) · Food & Function · doi:10.1039/d2fo02284b · Cited by 10
Zhang, X., Zhang, T., Tuo, W., Liu, Y., Umar, T., Chen, Y., Wu, Z., Zhou, Q., Li, X., Deng, G., et al. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215588 · Cited by 10
Self-citationSynthetic Cells and Molecules in Cellular Immunotherapy
Lin, H., Li, C., Zhang, W., Wu, B., Wang, Y., Wang, S., Wang, D., Li, X., & Huang, H. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.94346 · Cited by 12
“Despite the efficient cytotoxicity of CAR-T cells, CAR-T-induced targeted cell pyroptosis is still a problem as it is suspected with CRS induction [113].”
BackgroundYang, J., Ma, Y., Yu, J., Liu, Y., Xia, J., Kong, X., Jin, X., Li, J., Lin, S., Ruan, Y., et al. (2024) · Biomolecules · doi:10.3390/biom14101255 · Cited by 11
“GZMA cleaves GSDMB, causing pore formation on the membrane and inducing pyroptosis in target cells that express GSDMB. GZMB released by CAR-T cells can indirectly cleave GSDME by rapidly activating caspase-3 via the caspase3/GSDME-mediated pyroptotic pathway [56].”
BackgroundSelf-citationYang, B., Qi, Z., Díaz, Y. A., Cassotta, M., Grosso, G., Cianciosi, D., Zhang, D., Zou, X., Quiles, J. L., Battino, M. A., et al. (2025) · Nutrients · doi:10.3390/nu17030461 · Cited by 10
Smart responsive biomaterials for spatiotemporal modulation of functional tissue repair
He, X., Han, Z., Ruan, Y., Wang, Z., Liao, B., Li, X., Tan, J., Han, X., Shen, J., & Bai, D. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102063 · Cited by 27
Self-citationIranpour, S., Arif, M., & Szegezdi, É. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02133-w · Cited by 13
“Similar to GZMA, GZMB can also cleave and activate a gasdermin family member, GSDM, thereby inducing pyroptosis [ 86 ].”
Georgiou‐Siafis, S. K., Miliotou, Α. N., Ntenti, C., Pappas, I. S., & Papadopoulou, L. C. (2022) · Biomedicines · doi:10.3390/biomedicines10112885 · Cited by 10
“Regarding adverse reactions, CAR therapies have been associated with the cytokine release syndrome (CRS), a systemic response of excess inflammation, through cytokine release (IL-1, IL-6, IL-8, IFN-γ, GM-CSF) that can cause multiple organ failure and even death [20].”
BackgroundPyroptosis: A new insight of non-small-cell lung cancer treatment
Chen, X., Wu, J., & Wang, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1013544 · Cited by 13
“However, cytokine release syndrome (CRS) can be developed in this process, which is a serious and common side effect observed during CAR T-cell therapy (49, 50).”
BackgroundSelf-citationPyroptosis and Airway Homeostasis Regulation
Xu, P., LI, F., & TANG, H. (2023) · Physiological Research · doi:10.33549/physiolres.934971 · Cited by 11
A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse
Wang, S. S., Luong, K., Gracey, F. M., Jabar, S., McColl, B., Cross, R. S., & Jenkins, M. R. (2021) · Biomedicines · doi:10.3390/biomedicines9121875 · Cited by 10
“[39] which demonstrated that CAR T induced death via pyroptosis, a mode of cell death typically associated with infection, was mediated by the gasdermin E protein, leading to caspase 1 activation and triggering the inflammatory cascade of cytokine release syndrome [39].”
BackgroundResultInfluentialPyroptotic Patterns in Blood Leukocytes Predict Disease Severity and Outcome in COVID-19 Patients
Tang, Y., Zhang, P., Liu, Q., Cao, L., & Xu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888661 · Cited by 15
“Thus, pyroptosis plays a key role in the emergence of a cytokine storm, according to recent research (17, 19, 24).”
BackgroundNouri, Y., Weinkove, R., & Perret, R. (2023) · Current Protocols · doi:10.1002/cpz1.864 · Cited by 10
Delivery Systems Developed for Treatment Combinations to Improve Adoptive Cell Therapy
Xu, F., Ni, Q., Gong, N., Xia, B., Zhang, J., Guo, W., Hu, Z., Li, J., & Liang, X. (2024) · Advanced Materials · doi:10.1002/adma.202407525 · Cited by 13
Self-citationDual role of pyroptosis in liver diseases: mechanisms, implications, and therapeutic perspectives
Yang, S., Zou, Y., Zhong, C., Zhou, Z., Peng, X., & Tang, C. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1522206 · Cited by 20
Shang, D.-F., Xu, W.-Q., Zhao, Q. Y., Zhao, C., Wang, S.-Y., Han, Y., Li, H., Liu, M., & Zhao, W. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107754 · Cited by 11
Self-citationDeng, P., Jiang, J., Hu, C., Cao, L., & Li, M. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i5.1580 · Cited by 9
Overexpression of CASP1 triggers acute promyelocytic leukemia cell pyroptosis and differentiation
Yu, X., Liu, X., Liu, X., Jin, S., Zhong, M., Nie, D., Wang, X., Wang, X., Tan, J., Li, Y., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175614 · Cited by 10
Hsu, S., Chen, Y.-E., Shu, E.-D., Ko, C., Chang, W., Lin, I., Li, C., Gallego, R. P., & Chiu, C. (2023) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-023-00678-9 · Cited by 10
“Of note, the levels of LDH and GSDME are positively correlated with CRS severity (Liu et al. 2020).”
BackgroundAre all cytokine storms the same?
Panoskaltsis, N. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02822-2 · Cited by 11
Wang, Y., Shi, L., Xu, M., Yu, J., Sun, C., Yang, J., Wang, R., Sheng, N., Zhang, C.-F., Zhang, L., et al. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-1635 · Cited by 9
“Recent research showed that cytokine release syndrome (CRS) caused by chimeric antigen receptor T cells (CAR-T) is related to pyroptosis induced by DFNA5 and GSDMD (14).”
BackgroundRETRACTED ARTICLE: Molecular and therapeutic effect of CRISPR in treating cancer
Rodrigo, S., Senasinghe, K., & Quazi, S. (2023) · Medical Oncology · doi:10.1007/s12032-022-01930-6 · Cited by 11
RetractedPyroptosis in Skeleton Diseases: A Potential Therapeutic Target Based on Inflammatory Cell Death
Wu, Q., Du, J., Bae, E. J., & Choi, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169068 · Cited by 10
“First, in the context of chimeric antigen receptor T-cell (CAR-T) immunotherapy, granzyme B released by CAR-T cells was shown to activate the caspase-3/GSDME axis in tumor cells, inducing pyroptosis [137].”
BackgroundAnti-PD-1 exacerbates bleomycin-induced lung injury in mice via Caspase-3/GSDME-mediated pyroptosis
Wang, F., Deng, H., Zhou, M., Yang, Y., Zhou, J., Wang, Y., Xiaohong, X., Lin, X., Liu, M., Sun, G., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-024-07319-9 · Cited by 11
Self-citationHu, Y., Huang, Y., Guo, J., Liu, X., & Liu, Y. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02151-8 · Cited by 8
Self-citationGasdermins: multifunctional effectors of membrane permeabilization across cellular compartments
Margheritis, E. G., Gehle, N., & Cosentino, K. (2025) · FEBS Journal · doi:10.1111/febs.70215 · Cited by 11
“Immune cell recruitment upon GSDME activation is indeed fundamental to expanding several innovative therapeutic strategies, such as anti-PD1 and CAR T-cell treatment [176,177].”
Pyroptosis: Turning Up the Heat on Cancer
Zhang, Z., & Lieberman, J. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082423-041848 · Cited by 9
Self-citationRegulation of gasdermins in pyroptosis and cytokine release
Li, S., Bracey, S., Liu, Z., & Xiao, T. S. (2023) · Advances in immunology · doi:10.1016/bs.ai.2023.03.002 · Cited by 10
Zhu, Y., Wang, Z., Zheng, J., Wang, J., Chen, Y., Huang, C., & Zhou, H. (2023) · Gene · doi:10.1016/j.gene.2023.147888 · Cited by 10
Self-citationDeciphering the Role of Pyroptosis Impact on Cardiovascular Diseases
Patil, P., & Doshi, G. (2023) · Current Drug Targets · doi:10.2174/0113894501267496231102114410 · Cited by 10
Li, Y., Zhou, Z., Yu, H., Liu, Y., Huang, D., Wang, J., & Lin, X. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.02.001 · Cited by 9
Self-citationYan, Y., Cao, X., Wang, Z., Huang, Z., Cai, J., Tang, P., Yang, C., Zhang, F., Xia, S., & Shen, B. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.815290 · Cited by 9
“Other gasdermin molecules, particularly gasdermin E (GSDME), can be cleaved by caspase-3 to induce pyroptosis (Liu et al., 2020).”
BackgroundSelf-citationZhang, H., Yu, X., Yang, J., He, G., Zhang, X., Wu, X., Li, S., Zhou, Y., Cheng, X., Liu, X., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933779 · Cited by 10
“Chimeric antigen receptor (CAR) T cells can activate the caspase 3–GSDME pathway via releasing perforin and granzyme B to trigger pyroptosis in B leukemic cells (22).”
BackgroundSelf-citationDeterminants for Antitumor and Protumor Effects of Programmed Cell Death
Workenhe, S. T., Inkol, J. M., Westerveld, M. J., Verburg, S. G., Worfolk, S. M., Walsh, S. R., & Kallio, K. L. F. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0321 · Cited by 7
Gasdermin-mediated pyroptosis confers anticancer immunity
Lin, W., Lin, B., Zhou, Q., & Teng, L. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008162 · Cited by 8
“4 Notably, another study showed that pyroptosis induced in melanoma cells by GSDME and caspase-3 led to high-mobility group box1 (HMGB1) release, directly correlating with tumor-associated T cell activation and dendritic cell infiltration.”
BackgroundBates, S. M., Evans, K. V., Delsing, L., Wong, R., Cornish, G. H., & Bahjat, M. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104239 · Cited by 11
Donor macrophage pyroptosis contributes to the development of aGVHD
Sun, X., Qu, Q., Chen, Q., Liu, F., Fu, H., Chen, Y., Li, M., He, Y., Zhu, X., Zhao, X., et al. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2908-8 · Cited by 7
“In general, the inducers of pyroptosis are highly varied and include multiple PAMPs, DAMPs (Yu et al., 2021), metabolites (Guo et al., 2019; Zhang et al., 2021) and even lymphocytes (Liu et al., 2020b; Zhang et al., 2020; Zhou et al., 2020).”
Self-citationXiang, J., Zheng, Y., Chen, D., Zeng, Y., Zhang, J., Chang, D., & Chang, C. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1579539 · Cited by 16
Tan, D., Li, G., Li, X., Zhai, W., & Jing, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1734653 · Cited by 9
Luan, C., Wang, H., Zhou, J., Long, Z., Chen, X., Chen, X., Ni, J., Huang, Z., Xia, R., & Ge, J. (2023) · Biomedical Technology · doi:10.1016/j.bmt.2023.01.002 · Cited by 7
Self-citationWang, W., & He, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1203687 · Cited by 7
“GZMB secreted by CTLs or CAR-T cells could cleave GSDME directly at the site consistent with caspase-3 (79, 80).”
BackgroundSha, Y., Jiang, R., Miao, Y., Qin, S., Wu, W., Xia, Y., Wang, L., Fan, L., Jin, H. Z., Xu, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.939978 · Cited by 9
Gong, M., Liu, X., Zhao, X., & Wang, H. (2022) · BMC Cancer · doi:10.1186/s12885-022-09856-y · Cited by 8
Wang, H., Zhang, B., Shang, Y., Chen, F., Fan, Y., & Tan, K. (2023) · Aging · doi:10.18632/aging.204544 · Cited by 8
“Pyroptosis-associated factors in turn activate caspase-1 in macrophages, leading to cleavage of GSDMD, which ultimately induces cytokine release syndrome [46].”
Hu, X., Yin, H., Xie, D., Chen, T., Li, Y., Zeng, H., Lu, M., & Wang, Q. (2024) · Advanced Science · doi:10.1002/advs.202305934 · Cited by 7
Huang, H., Hu, Y., Zhou, Y., Zhang, M., Zhao, H., Wei, G., Ge, W., Chen, G., Han, L., Guo, T., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-514812/v1 · Cited by 7
Self-citationDeregulation of New Cell Death Mechanisms in Leukemia
Favale, G., Donnarumma, F., Capone, V., Torre, L. D., Beato, A., Carannante, D., Verrilli, G., Nawaz, A., Grimaldi, F., Simone, M. C. D., et al. (2024) · Cancers · doi:10.3390/cancers16091657 · Cited by 7
“The application of CAR-T therapy, an immunotherapy approach against the ALL cluster of differentiation 19 (CD19 + ) blasts, induces an alternative form of pyroptosis which involves both GSDME/GSDMD together with a cytokine release syndrome [52].”
Ma, H., & Zhu, L. (2024) · Medicine · doi:10.1097/md.0000000000039685 · Cited by 7
“[49] The former can be activated by Caspase-3 or directly cleaved by GSDME, while the latter can be directly cleaved by GSDMB, resulting in pyroptosis-induced cells.”
BackgroundShi, N., Wei, L., Wang, H., Sun, S., Yang, J., & Zhou, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1626566 · Cited by 7
Self-citationMoreno‐Castaño, A. B., Iraola, G., Martínez‐Cibrián, N., Albiol, N., Prats, D.-N. M., Martínez-Sánchez, J., Castro, P., & Díaz‐Ricart, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1699894 · Cited by 8
Chen, Y., Wang, J., Dai, Q., Chen, P., Wang, H., Li, R., Gu, Y., Liu, H., Xiao, H., Qin, S., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2025.123973 · Cited by 9
Nwozichi, C. U., Ogunmuyiwa, A. O., & Ojewale, M. O. (2023) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2023.100367 · Cited by 11
“17 It is believed that pyroptosis of the target cell represents the onset of CRS. 18 CRS is known to represent one of the most frequent serious adverse effects of CAR-T therapy.”
BackgroundCAR cell design strategies in solid tumors
Wang, L., Chen, X., Zhang, L., Niu, B., Li, L., Sun, Y., & Yuan, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109345 · Cited by 8
Self-citationNakagawa, N., Fujisawa, Y., Xiang, H., Kitamura, H., & Nishida, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119457 · Cited by 6
“Granzyme B has been shown to be involved in tumor suppression by activating gasdermin E, which is involved in cellular pyroptosis [21,22], and is also known to play an important role in tumor immunity.”
BackgroundDual identity of tumor-associated macrophage in regulated cell death and oncotherapy
Shao, Y., Wang, Y., Su, R., Pu, W., Chen, S., Fu, L., Yu, H., & Qiu, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17582 · Cited by 7
“7 Pyroptosis-releasing factor activates GSDMD-cleaved caspase-1 in macrophages, leading to cytokine release and subsequent cytokine release syndrome (CRS), which inhibits chimeric antigen receptor (CAR) T cell therapy for patients [56].”
BackgroundBarar, E., & Shi, J. (2023) · Biomedicines · doi:10.3390/biomedicines11102792 · Cited by 6
“Additionally, the high-risk group had more tumor mutations [73], consistent with the study conducted by Xu and colleagues using different PRGs to develop risk models [74].”
BackgroundResultNanomaterial-induced pyroptosis: a cell type-specific perspective
Wang, Z., Wang, M., Zeng, X., Yue, X., & Pei, W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1322305 · Cited by 6
Self-citationPerspectives of the Danger/Injury Model of Immunology as Applied to Antigen-Related Human Disorders
Land, W. G. (2023) · Springer eBooks · doi:10.1007/978-3-031-21776-0_1 · Cited by 7
Metadata
- Authors
- Liu, Y., Fang, Y., Chen, X., Wang, Z., Liang, X., Zhang, T., Liu, M., Zhou, N., Lv, J., Tang, K., Xie, J., Gao, Y., Cheng, F., Zhou, Y., Zhang, Z., Hu, Y., Zhang, X., Gao, Q., Zhang, Y., & Huang, B.
- Affiliations
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Huazhong University of Science and Technology (CN)
- Wuhan Union Hospital (CN)
- Peking University People's Hospital (CN)
- Zhengzhou University (CN)
- Corresponding author
- Liu, Yuying
- Fang, Yiliang
- Chen, Xinfeng
- Huang, Bo
- ORCID
- Venue
- Science Immunology
- Published
- 2020-01-03
- Volume
- 5
- Issue
- 43
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2999534343
- Cited by
- 566
- References
- 45
- Citations by year
- 2026: 63 · 2025: 87 · 2024: 100 · 2023: 127 · 2022: 96 · 2021: 70 · 2020: 22
- FWCI
- 28.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81788101, 81661128007, 81530080, 81773062)
- Topics
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- gasdermin E, pyroptosis, chimeric antigen receptor T cells, cytokine release syndrome, macrophage activation, inflammatory cytokines, target cell death, adoptive T cell therapy
- MeSH terms
- Pyroptosis, Cytokine Release Syndrome, Gasdermins, Animals, Female, Humans, Macrophages, T-Lymphocytes, Leukemia, B-Cell, Immunotherapy, Adoptive, Phosphate-Binding Proteins, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Mice, Granzymes, Perforin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.